Antimetabolite-metabolite combination cancer chemotherapy.Effects of intra-arterial methotrexate—intramuscular citrovorum factor therapy in human cancer

This publication has 30 references indexed in Scilit:

• SUMMARY OF RESULTS OBTAINED WITH NITROGEN MUSTARD IN THE TREATMENT OF NEOPLASTIC DISEASE
  Annals of the New York Academy of Sciences, 1958
• FUTURE EXPERIMENTAL APPROACHES
  Annals of the New York Academy of Sciences, 1958
• Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory Compounds
  Nature, 1957
• Involvement of Atp, 5-Phosphoribosyl-Pyrophosphate and L-Azaserine in the Enzymatic Formation of Glycinamide Ribotide Intermediates in Inosinic Acid Biosynthesis
  Journal of the American Chemical Society, 1955
• STUDIES ON THE TOXICITY AND ANTILEUKEMIC ACTION OF 6‐MERCAPTOPURINE IN MICE
  Annals of the New York Academy of Sciences, 1954
• Clinical trials of O-diazoacetyl-L-serine (azaserine) in neoplastic disease
  Cancer, 1954
• The effects of the folic acid antagonists and 2,6-diaminopurine on neoplastic disease.With special reference to acute leukemia
  Cancer, 1951
• Prevention of Toxicity of Massive Doses of A-methopterin by Gitrovorum Factor.
  Experimental Biology and Medicine, 1951
• Prevention of Chemotherapeutic Effects of 4-Amino-N10-Methyl-Pteroyl-glutamic Acid on Mouse Leukemia by Citrovorum Factor.
  Experimental Biology and Medicine, 1950
• Temporary Remissions in Acute Leukemia in Children Produced by Folic Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin)
  New England Journal of Medicine, 1948